Please login to the form below
Trishna Bharadia
This page shows the latest Trishna Bharadia news and features for those working in and with pharma, biotech and healthcare.
Latest Intelligence
-
Case study: The World vs MS
In doing this, we are helping to raise greater awareness and understanding of MS and, therefore, make life easier for people affected by the condition.” Trishna Bharadia, MS advocate; Ambassador for
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Mistrust in medical research: a patient perspective
Patient advocate, Trishna Bharadia reveals what the life sciences industry can do to rebuild trust.
-
Outsourcing in Clinical Trials 2020 Virtual Conference
All about maximising the patient experience. We heard from Zach Hales ( Greenphire) and Trishna Bharadia (Health Advocate and Patient Engagement Champion) about how important it is to understand key barriers to
-
Diagnosing MS: are we getting it right?
Multi-award-winning patient advocate, Trishna Bharadia, walks through the complications involved with an MS diagnosis, including the challenges for healthcare systems and a handful of insightful patient stories.
-
Empowering the MS patient through shared decision making
Patient advocate Trishna Bharadia explains why shared decision making is crucial for ensuring multiple sclerosis patients feel heard and empowered.
-
Six factors that drive a multiple sclerosis patient's choice of disease-modifying therapy
MS advocate Trishna Bharadia explains the numerous factors that lead patients to choose a disease-modifying therapy, including the important considerations healthcare professionals and pharma often forget.
More from PMHub
Approximately 1 fully matching, plus 7 partially matching documents found.
Subscribe to our email news alerts
- COVID-19 could be key in identifying viruses with pandemic potential
- Novo Nordisk Foundation commits €127m for new cell therapy facility
- Alzheimer’s Research UK launches ‘Change The Ending’ campaign
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
No results were found
PMHub
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
